SCHEMBL7482012

SCHEMBL7482012

CN1CCN(c2ccc(C=CC(=O)O)cn2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM2 Q9P1W9 3/20 0.54
KDM4E B2RXH2 2/20 0.52
ALDH1A1 P00352 2/20 0.52
PIM1 P11309 2/20 0.50
CSNK2A2 P19784 1/20 0.50
CSNK2A1 P68400 1/20 0.50
P4HTM Q9NXG6 1/20 0.50
ESR1 P03372 1/20 0.49
HDAC3 O15379 3/20 0.48
HDAC4 P56524 3/20 0.48
HDAC1 Q13547 3/20 0.48
HDAC7 Q8WUI4 3/20 0.48
HDAC2 Q92769 3/20 0.48
HDAC10 Q969S8 3/20 0.48
HDAC11 Q96DB2 3/20 0.48
HDAC8 Q9BY41 3/20 0.48
HDAC6 Q9UBN7 3/20 0.48
HDAC9 Q9UKV0 3/20 0.48
HDAC5 Q9UQL6 3/20 0.48
USP2 O75604 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7482002 1.00 PIM2 (0.54) PIM2KDM4EALDH1A1PIM1CSNK2A2
SCHEMBL7657058 0.87 P4HTM (0.54) PIM2KDM4EALDH1A1PIM1CSNK2A2
SCHEMBL7657066 0.87 P4HTM (0.54) PIM2KDM4EALDH1A1PIM1CSNK2A2
SCHEMBL4619798 0.86 P4HTM (0.53) PIM2KDM4EALDH1A1PIM1CSNK2A2
SCHEMBL3786486 0.83 PIM2 (0.54) PIM2KDM4EALDH1A1P4HTMESR1
SCHEMBL3786488 0.83 PIM2 (0.54) PIM2KDM4EALDH1A1P4HTMESR1
SCHEMBL29551688 0.83 PIM2 (0.54) PIM2KDM4EALDH1A1P4HTMESR1
SCHEMBL23916212 0.81 MAPT (0.48) KDM4EALDH1A1USP2RAB9AL3MBTL1
SCHEMBL15492286 0.81 MAPT (0.48) KDM4EALDH1A1USP2RAB9AL3MBTL1
SCHEMBL2322917 0.79 ALDH1A1 (0.57) ALDH1A1USP2RAB9AL3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6462047-B1 CONTAINING 5- OR 6-MEMBERED OXYGEN, NITROGEN AND/OR SULFUR HETEROARYL GROUP; ANGINA, HYPERTENSION, RESPIRATORY DISTRESS, CONGESTIVE HEART FAILURE, RENAL FAILURE, ATHEROSCLEROSIS, INFLAMMATORY DISEASES, STROKES, BRONCHITIS, ASTHMA ICOS CORPORATION 2002-10-08 US disclosed
EP-1114048-A1 CARBOLINE DERIVATIVES AS CGMP PHOSPHODIESTERASE INHIBITORS Bombrun, Agnès (FR) 2001-07-11 EP disclosed
WO-2000015639-A1 CARBOLINE DERIVATIVES AS CGMP PHOSPHODIESTERASE INHIBITORS ICOS CORPORATION (US) 2000-03-23 WO disclosed